Evidence map›Paper›PMID 36536850›Full record

ArticleAJOG global reports2022

Prevalence of cannabis use disorder among pregnant people who test positive for cannabis at time of delivery.

Cassie Wicken, Anant Walia, Soroosh Solhjoo, Katrina Mark

Open access · goldAbstract read
In one paragraph

Article in AJOG global reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Timing matters: modeling the effects of gestational cannabis exposure on social behavior and microglia in the developing amygdala.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2025
    Article
  3. Article
  4. Article
  5. Cannabis and Pregnancy: A Review.Obstetrical & gynecological survey · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Cassie WickenUniversity of Maryland School of Medicine, Baltimore MD (Ms Wicken, Anant Walia, and Dr Mark).
Anant WaliaUniversity of Maryland School of Medicine, Baltimore MD (Ms Wicken, Anant Walia, and Dr Mark).
Soroosh SolhjooJohns Hopkins University School of Medicine, Baltimore MD (Dr Solhjoo).
Katrina MarkUniversity of Maryland School of Medicine, Baltimore MD (Ms Wicken, Anant Walia, and Dr Mark).
University of Maryland, Baltimore · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCannabis use in pregnancy is common, but the reasons that some pregnant people continue use are unclear.

objectiveThis study aimed to assess the prevalence of cannabis use disorder and medicinal cannabis use among pregnant people who test positive for cannabis use at the time of delivery at a single institution. STUDY

designA standardized questionnaire was administered to postpartum people who tested positive for cannabis use by urine toxicology at the time of admission to the obstetrical care unit at the University of Maryland Medical Center. The questionnaire included questions modeled after the National Survey on Drug Use and Health's assessment of cannabis use disorder. The questionnaire also asked the respondent to indicate which symptoms, if any, they used cannabis to treat and whether cannabis had been recommended by a physician.

resultsOf 46 study respondents, 12 (26.1%) met the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, criteria for cannabis use disorder. Among the 37 respondents who answered questions about physician recommendation and treatment of symptoms, 28 (75.7%) reported using cannabis for symptom control, most commonly nausea or vomiting. Of note, 2 respondents reported having been recommended cannabis by a physician before they became pregnant but not specifically after becoming pregnant. Moreover, 31 of 35 respondents (88.5%) indicated that they intended to stop using cannabis during pregnancy.

conclusionHere, a quarter of birthing people who tested positive for cannabis use at the time of delivery met the cannabis use disorder criteria. Further investigation is needed to identify barriers and unmet needs for substance use treatment.

Indexed as

addictioncannabis use disordermarijuanapregnancy

Identifiers

PMID36536850
PMCPMC9758330
OpenAlexW4294308397

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.